Notice of the Fourth Extraordinary General Meeting of Shareholders in 2026

Guangji Pharmaceutical Co., Ltd.·July 20, 2026·7 pages

✨ AI Summary

Hubei Guangji Pharmaceutical Co., Ltd. announces its fourth extraordinary general meeting of shareholders in 2026, scheduled for August 5, 2026. The meeting will discuss proposals related to the company's issuance of A-shares to specific objects. Key decisions involve approving the plan, related reports, and authorizing the board to handle the issuance.

Summary generated by AI · Always verify with source document

Exchange Summary

EGM-ONLINE

The Company will hold the 4th Extraordinary General Meeting of 2026 at 15:30 on 05 August 2026. Meeting agenda: 1. The Company's eligibility for A-share offering to specific parties 2. Adjustment of the plan for the 2026 A-share offering to specific parties 2.1. Stock type and par value 2.2. Method and date of issuance 2.3. Issuing targets and subscription method 2.4. Pricing base date, pricing principles and issue price 2.5. Issuing volume 2.6. Lockup period arrangement 2.7. Purpose and amount of the raised funds 2.8. Arrangement for the accumulated retained profits 2.9. Listing place 2.10. Valid period of the resolution 3. Preplan for the 2026 A-share offering to specific parties (revised) 4. Demonstration analysis report on the plan for 2026 A-share offering to specific parties (revised) 5. Feasibility analysis report on the use of funds to be raised from the 2026 A-share offering to specific parties (revised) 6. Diluted immediate return after the 2026 A-share offering to specific parties, filling measures, and commitments of relevant parties 7. No need to prepare a report on the use of previous raised funds 8. Connected transactions regarding the conditional share subscription agreement and its supplementary agreement to be signed with specific parties 9. Connected transactions involved in the 2026 A-share offering to specific parties 10. Full authorization to the board to handle matters regarding the A-share offering to specific parties 11. Shareholder return plan for the next three years from 2026 to 2028 12. Exemption of specific parties from the tender offer obligation Meeting attendees: 1. A-share holders registered at CSDC Shenzhen after the close of trading on 30 July 2026 are entitled to vote. Original notarized power of attorney for voting is required. 2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting. Registration period: from 04 August 2026 to 04 August 2026 The Company's shareholder may choose to vote online via the trading system of Shenzhen Stock Exchange or via the website of http://wltp.cninfo.com.cn. Part I Voting via the trading system Voting date: 05 August 2026 Voting code:360952 Voting abbreviation:Guangji Pharm. voting Voting process: 1. To input the "buy" instruction to begin voting 2. To input the serial number of the Investors Meeting proposals under the item of "subscription price" "1 share" for voting for, "2 shares" for voting against and "3 shares" for "abstention". Part II Voting via the internet Shareholders may choose the CA (certification authority) or service password for identity verification. As to the service password, shareholders may apply for a password on the website http://www.szse.cn or http://wltp.cninfo.com.cn. Voting period: from 05 August 2026 to 05 August 2026.

Provided by Shenzhen Stock Exchange

Full Translation

AI Translation· gemini_document

Notice of the Fourth Extraordinary General Meeting of Shareholders in 2026

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, and there are no false records, misleading statements, or major omissions.

I. Basic Situation of the Meeting

Session of the Shareholders' Meeting: Fourth Extraordinary General Meeting of Shareholders in 2026
Convener of the Shareholders' Meeting: Board of Directors
The convening and holding of this meeting comply with the "Company Law of the People's Republic of China," the "Shenzhen Stock Exchange Stock Listing Rules," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 1 - Norms for the Operation of Main Board Listed Companies," and other laws, administrative regulations, departmental rules, normative documents, and the "Articles of Association."
Meeting Time:

(1) On-site Meeting Time: August 5, 2026, 15:30

(2) Online Voting Time: The specific time for online voting through the Shenzhen Stock Exchange trading system is August 5, 2026, 9:15-9:25, 9:30-11:30, 13:00-15:00; the specific time for voting through the Shenzhen Stock Exchange internet voting system is any time from August 5, 2026, 9:15 to 15:00.

Meeting Method: Combination of on-site voting and online voting.
Equity Registration Date: July 30, 2026
Attendees:

(1) Common shareholders of the company or their authorized representatives holding shares on the equity registration date;

All common shareholders of the company registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited as of the close of trading on the afternoon of the equity registration date (July 30, 2026) are entitled to attend this shareholders' meeting and may, by written power of attorney, authorize an agent to attend the meeting and vote. The authorized agent does not need to be a shareholder of the company (see Attachment II for the Power of Attorney).

(2) Directors, Senior Management Personnel;

(3) Lawyers hired by the company;

(4) Other personnel who should attend the shareholders' meeting according to relevant regulations.

Meeting Location: Conference Room, 2nd Floor, Administration Building, Dajin Industrial Park, No. 100 Meiwu Road, Dajin Town, Wuxue City, Hubei Province

II. Matters to be Reviewed at the Meeting

Table of Proposals for the Shareholders' Meeting

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.